Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.24%
1,103.05
+2.67
+0.24%
1,100.381,096.191,112.971,094.08
SIXC
Communications
SIXC
Communications
SIXC
+0.19%
622.42
+1.21
+0.19%
621.21621.21624.47618.56
SIXE
Energy
SIXE
Energy
SIXE
-2.87%
1,157.44
-34.22
-2.87%
1,191.661,158.281,160.761,124.17
SIXI
Industrials
SIXI
Industrials
SIXI
+1.82%
1,750.30
+31.25
+1.82%
1,719.051,729.911,766.941,729.91
SIXM
Financials
SIXM
Financials
SIXM
+0.75%
646.61
+4.84
+0.75%
641.77643.39653.21643.39
SIXR
Staples
SIXR
Staples
SIXR
+1.26%
833.78
+10.40
+1.26%
823.38822.99834.38820.61
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.54%
218.49
+3.31
+1.54%
215.18215.18218.76215.18
SIXT
Technology
SIXT
Technology
SIXT
+1.50%
3,109.02
+45.83
+1.50%
3,063.193,096.933,118.043,093.29
SIXU
Utilities
SIXU
Utilities
SIXU
-0.42%
935.18
-3.92
-0.42%
939.10937.35937.41924.95
SIXV
Health care
SIXV
Health care
SIXV
+1.45%
1,503.60
+21.56
+1.45%
1,482.041,485.591,506.801,485.59
SIXY
Discretionary
SIXY
Discretionary
SIXY
+2.36%
2,435.30
+56.09
+2.36%
2,379.212,409.512,463.802,409.51
AN2 Therapeutics Inc
$3.61
+14.97%
(+0.47) 1D
$3.74
+3.60% (+0.13)
After hours
Closed: Apr 17, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANTX...
Open
$3.20
High
$3.65
Low
$3.09
Mkt. cap
129.75M
Avg. vol.
2.79M
Volume
506.38K
52-wk high
$6.91
52-wk low
$1.00
EPS
-$1.16
Beta
-1.31
Shares outstanding
35.95M
No. of employees
21
News stories
From sources across the web
About AN2 Therapeutics Inc
CEO-
Employees21
Founded2017
HeadquartersMenlo Park, California, United States
SectorPharmaceutical industry
Last report
Mar 17, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.29/ (-0.24 est.)USD
-20.83%miss
Revenue / Estimate
-/ (0.00 est.)USD
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.69M
3.20M
7.00M
6.88M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.85M
4.02M
3.04M
2.44M
Operating expense
11.54M
7.22M
10.04M
9.32M
Total operating expenses
11.54M
7.22M
10.04M
9.32M
Operating income
-11.54M
-7.22M
-10.04M
-9.32M
Other non operating income
-
-
-
1.00K
EBT including unusual items
-10.65M
-6.46M
-9.35M
-8.71M
EBT excluding unusual items
-10.65M
-6.46M
-9.35M
-8.71M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.65M
-6.46M
-9.35M
-8.71M
Net profit margin
-
-
-
-
Earnings per share
-0.35
-0.21
-0.31
-0.29
Interest and investment income
888.00K
754.00K
687.00K
605.00K
Interest expense
-
-
-
-
Net interest expenses
888.00K
754.00K
687.00K
605.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more